Arrowhead Pharmaceuticals
ARWR
#4033
Rank
A$3.57 B
Marketcap
$28.73
Share price
-13.26%
Change (1 day)
-31.84%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2024 (TTM): -A$0.8 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are A$19.64 Million. In 2023 the company made an earning of -A$0.44 Billion a decrease over its 2022 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.8 Billion81.44%
2023 -A$0.44 Billion87.79%
2022 -A$0.24 Billion-20.1%
2021 -A$0.3 Billion67.59%
2020 -A$0.18 Billion-347.53%
2019 A$70.23 M-245.59%
2018 -A$48.24 Million-13.17%
2017 -A$55.56 Million-52.28%
2016 -A$0.12 Billion-16.57%
2015 -A$0.14 Billion30.32%
2014 -A$0.11 Billion171.62%
2013 -A$39.43 Million16.56%
2012 -A$33.83 Million107.53%
2011 -A$16.3 Million
2008 -A$57.41 Million-8.07%
2007 -A$62.45 Million70.37%
2006 -A$36.66 Million122.51%
2005 -A$16.48 Million147.41%
2004 -A$6.66 Million2002.28%
2003 -A$0.32 Million-85.61%
2002 -A$2.21 Million1371.97%
2001 -A$0.15 Million-13.45%
2000 -A$0.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.29 Billion-64.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion-77.62%๐Ÿ‡บ๐Ÿ‡ธ USA
A$84.4 M-110.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion-77.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.46 B-3,599.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$6.66 Billion 718.74%๐Ÿ‡บ๐Ÿ‡ธ USA